There were 15 treatment-related deaths in the chemotherapy-plus-bevacizumab group, including 5 from pulmonary hemorrhage.

• 紫杉醇-卡铂-贝伐单抗治疗组有15例治疗相关性死亡病例，其中5例为肺出血。